Mental health of school-aged children treated with propranolol or atenolol for infantile hemangioma and their parents
Publication date
2024-04
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by
Abstract
Background: Infants with infantile hemangioma (IH) have been effectively treated with propranolol or atenolol. Concerns were raised about the mental health of these The trial registration: Netherlands Trial Register Trial NL7703.children at school age, due to central nervous system effects of propranolol and visible nature of IH. Objective: This study aimed to compare the mental health at school age of children treated with propranolol to children treated with atenolol for IHs and their parents. Methods: This two-centered cross sectional study included children aged =6 years and treated with either propranolol or atenolol for IH during infancy. Children’s outcomes were performance-based affect recognition (Dutch version of the Developmental Neuropsychological Assessment-II [NEPSY-II-NL]), parent-reported emotional and behavioral functioning (Child Behavioral Checklist [CBCL]), and health-related quality of life (KIDSCREEN27). Parents’ outcome was parenting stress (Parenting Stress Questionnaire [OBVL]). Results: Data of 105 children (36 propranolol, 69 atenolol; 6.0–11.8 years) were analyzed. Mental health outcomes did not differ between both ß-blocker groups. Although overall functioning was in line with norms, children presented specific problems concerning affect recognition, parent-reported attention, and social quality of life. Parents showed increased physical symptoms, depressive symptoms, and parent-child relationship problems. Conclusion: No difference in mental health at school age was found between children treated with propranolol or atenolol for IH. Although few overall mental health problems were found, specific problems require follow-up. Follow-up of children should be directed toward affect recognition, attention, and social functioning in daily life. Problems reported by parents could be ameliorated by mental health support during and after their infant’s ß-blocker treatment.
Keywords
Adrenergic beta-antagonists, Long-term adverse effects, Parenting, Psychosocial functioning, Vascular tissue neoplasms, Dermatology, Journal Article
Citation
Hermans, M M, Schappin, R, de Laat, P C J, Mendels, E J, Breur, J M P J, Langeveld, H R, Raphael, M F, de Graaf, M, Breugem, C C, de Wildt, S N, Okkerse, J M E, Pasmans, S G M A & Rietman, A B 2024, 'Mental health of school-aged children treated with propranolol or atenolol for infantile hemangioma and their parents', Dermatology, vol. 240, no. 2, pp. 216-225. https://doi.org/10.1159/000536144